The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention

  • William G Nelson

      Affiliations

    • Department of Oncology (WGN, AMD, TLD), The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Department of Medicine (WGN), The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Corresponding Author InformationReprint requests: William G. Nelson, MD, PhD, Marburg 411, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287
  • ,
  • Angelo M De Marzo

      Affiliations

    • Department of Urology (WGN, AMD, TLD), The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Department of Pharmacology (WGN), The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Theodore L DeWeese

      Affiliations

    • Department of Pathology (WGN, AMD), The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Abstract 

Prostate cancer has become 1 of the most commonly diagnosed cancers in the United States and 1 of the leading causes of cancer death in North America and Western Europe. Survey studies of prostate tissues obtained at autopsy indicate that the development of life-threatening prostate cancer in the US likely occurs over decades. Insights from epidemiologic studies implicate environmental factors, principally dietary components, as major risk factors for prostate cancer development. An accumulating body of basic research data suggests that normal and neoplastic prostate cells may be subjected to a relentless barrage of genome-damaging stresses, and that dietary components and male sex steroids might modulate the level of genome threatening insults. Finally, over the past 5 years, analyses of somatic genome alterations in prostatic carcinoma cells have revealed that somatic inactivation of GSTP1, encoding the carcinogen-detoxification enzyme glutathione S-transferase π, may serve as an initiating genome lesion for prostatic carcinogenesis. These diverse observations can be integrated into a transcendent mechanistic hypothesis for the pathogenesis of prostate cancer: normal prostate cells acquiring somatic GSTP1 defects may suffer chronic genome damage, influenced by dietary practices, that promote neoplastic transformation, while prostatic carcinoma cells, which characteristically contain defective GSTP1 alleles, remain susceptible to further genome-damaging stresses that promote malignant cancer progression. This hypothesized critical role for GSTP1 inactivation in the earliest steps of prostatic carcinogenesis provides several attractive opportunities for prostate cancer prevention strategies, including (1) restoration of GSTP1 function, (2) compensation for inadequate GSTP1 activity (via use of therapeutic inducers of other glutathione S-transferases (GST), and (3) abrogation or attenuation of genome-damaging stresses.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funded in part by National Cancer Institute Grants N. CA58326 and N. CA70196 and by an award from the Association for the Cure of Cancer of the Prostate (CaP CURE).

PII: S0090-4295(00)00939-0